Azithramycine

Azithramycine is a lipid of Polyketides (PK) class. Azithramycine is associated with abnormalities such as Respiratory Tract Infections, Pneumonia, Lower respiratory tract infection, Infection and Nonspecific urethritis. The involved functions are known as Lysis, Selection, Genetic, Mutation, Relapse and Adaptation. Azithramycine often locates in Blood, Respiratory System, Genitourinary system, Back and Chest. The associated genes with Azithramycine are Genes, rRNA, Genome, RPL22 gene, OPRM1 gene and tryptic soy broth. The related lipids are Liposomes, Phosphatidylserines, Promega, Lipopolysaccharides and Steroids. The related experimental models are Mouse Model, Knock-out and Tissue Model.

Cross Reference

Introduction

To understand associated biological information of Azithramycine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Azithramycine?

Azithramycine is suspected in Infection, Pneumonia, Trachoma, Respiratory Tract Infections, Gonorrhea, Infectious disease of lung and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Azithramycine

MeSH term MeSH ID Detail
Retinal Hemorrhage D012166 3 associated lipids
Mycobacterium Infections, Nontuberculous D009165 8 associated lipids
Dyspnea D004417 10 associated lipids
Angina, Unstable D000789 14 associated lipids
Heart Defects, Congenital D006330 20 associated lipids
Keratitis D007634 7 associated lipids
Stevens-Johnson Syndrome D013262 3 associated lipids
Food Hypersensitivity D005512 7 associated lipids
Lymphadenitis D008199 8 associated lipids
Drug Eruptions D003875 30 associated lipids
Vaginosis, Bacterial D016585 10 associated lipids
Amebiasis D000562 2 associated lipids
Lung Diseases, Parasitic D008174 2 associated lipids
Aortic Aneurysm, Abdominal D017544 5 associated lipids
Multiple Sclerosis, Relapsing-Remitting D020529 7 associated lipids
Pulmonary Disease, Chronic Obstructive D029424 16 associated lipids
Tooth Mobility D014086 2 associated lipids
Mitral Valve Stenosis D008946 3 associated lipids
Prostatitis D011472 5 associated lipids
Meningoencephalitis D008590 4 associated lipids
Cat Diseases D002371 12 associated lipids
Stomatitis D013280 14 associated lipids
Weight Loss D015431 56 associated lipids
Tendinopathy D052256 3 associated lipids
Tooth, Impacted D014095 9 associated lipids
Blister D001768 16 associated lipids
Ciliary Motility Disorders D002925 2 associated lipids
Dry Eye Syndromes D015352 10 associated lipids
Corynebacterium Infections D003354 7 associated lipids
Opportunistic Infections D009894 8 associated lipids
Acute Lung Injury D055371 33 associated lipids
Rhabdomyolysis D012206 9 associated lipids
Keratosis D007642 9 associated lipids
Fetal Membranes, Premature Rupture D005322 4 associated lipids
Gingival Overgrowth D019214 7 associated lipids
Actinomycetales Infections D000193 4 associated lipids
Pneumonia, Bacterial D018410 16 associated lipids
Rosacea D012393 13 associated lipids
Parasitemia D018512 5 associated lipids
Long QT Syndrome D008133 10 associated lipids
Gonorrhea D006069 7 associated lipids
Malaria, Falciparum D016778 22 associated lipids
Haemophilus Infections D006192 3 associated lipids
Neurotoxicity Syndromes D020258 34 associated lipids
Abortion, Spontaneous D000022 12 associated lipids
Helicobacter Infections D016481 21 associated lipids
Psychomotor Agitation D011595 3 associated lipids
Lymphoma, B-Cell D016393 24 associated lipids
Community-Acquired Infections D017714 8 associated lipids
Mucositis D052016 7 associated lipids
Mycobacterium avium-intracellulare Infection D015270 4 associated lipids
Dysentery, Bacillary D004405 6 associated lipids
Infectious Mononucleosis D007244 5 associated lipids
Anaplasmataceae Infections D000711 3 associated lipids
Pouchitis D019449 3 associated lipids
AIDS-Related Opportunistic Infections D017088 9 associated lipids
Cryptosporidiosis D003457 3 associated lipids
Skin Diseases, Bacterial D017192 8 associated lipids
Neglected Diseases D058069 3 associated lipids
Giardiasis D005873 3 associated lipids
Chronic Disease D002908 7 associated lipids
Tick Infestations D013984 4 associated lipids
Retinitis D012173 4 associated lipids
Common Variable Immunodeficiency D017074 4 associated lipids
Purpura, Thrombocytopenic, Idiopathic D016553 4 associated lipids
Skin Diseases, Vesiculobullous D012872 5 associated lipids
Chlamydia Infections D002690 7 associated lipids
Legionnaires' Disease D007877 4 associated lipids
Whooping Cough D014917 6 associated lipids
Urethritis D014526 9 associated lipids
Boutonneuse Fever D001907 5 associated lipids
Yaws D015001 4 associated lipids
Syphilis, Latent D013592 4 associated lipids
Mycoplasmatales Infections D009180 6 associated lipids
Vertigo D014717 4 associated lipids
Pelvic Pain D017699 7 associated lipids
Pneumonia, Pneumococcal D011018 3 associated lipids
Leishmaniasis, Cutaneous D016773 6 associated lipids
Bronchiolitis Obliterans D001989 8 associated lipids
Exanthema D005076 11 associated lipids
Lyme Disease D008193 5 associated lipids
Bronchiolitis D001988 6 associated lipids
Chlamydophila Infections D023521 4 associated lipids
Gingival Hyperplasia D005885 3 associated lipids
Communicable Diseases, Emerging D021821 3 associated lipids
Ureaplasma Infections D016869 5 associated lipids
Erythema Nodosum D004893 5 associated lipids
Pemphigus D010392 3 associated lipids
Trichomonas Infections D014245 3 associated lipids
Acinetobacter Infections D000151 4 associated lipids
Scalp Dermatoses D012536 11 associated lipids
Picornaviridae Infections D010850 4 associated lipids
Failed Back Surgery Syndrome D055111 3 associated lipids
Uveitis, Intermediate D015867 3 associated lipids
Digestive System Diseases D004066 3 associated lipids
Multiple Pulmonary Nodules D055613 2 associated lipids
Pneumonia, Mycoplasma D011019 6 associated lipids
Neisseriaceae Infections D016870 3 associated lipids
Desulfovibrionaceae Infections D045824 5 associated lipids
Chancroid D002602 4 associated lipids
Per page 10 20 50 100 | Total 276

PubChem Associated disorders and diseases

What pathways are associated with Azithramycine

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Azithramycine?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Azithramycine?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Azithramycine?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Azithramycine?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Azithramycine?

Mouse Model

Mouse Model are used in the study 'Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa.' (Cory TJ et al., 2013), Mouse Model are used in the study 'Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.' (Miyazaki S et al., 2001), Mouse Model are used in the study 'Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.' (Gross M et al., 2004), Mouse Model are used in the study 'Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections.' (Bala A et al., 2011) and Mouse Model are used in the study 'Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.' (Girard D et al., 2005).

Knock-out

Knock-out are used in the study 'Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin.' (Bulman ZP et al., 2017) and Knock-out are used in the study 'Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.' (Mulet X et al., 2009).

Tissue Model

Tissue Model are used in the study 'Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects.' (Zheng S et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Azithramycine

Download all related citations
Per page 10 20 50 100 | Total 4404
Authors Title Published Journal PubMed Link
pmid:
pmid:21439162
Zhou QT et al. How Much Surface Coating of Hydrophobic Azithromycin Is Sufficient to Prevent Moisture-Induced Decrease in Aerosolisation of Hygroscopic Amorphous Colistin Powder? 2016 AAPS J pmid:27255350
Gandhi SV et al. Considerations for a Pediatric Biopharmaceutics Classification System (BCS): application to five drugs. 2014 AAPS PharmSciTech pmid:24557773
Shunmugaperumal T and Kaur V In Vitro Anti-inflammatory and Antimicrobial Activities of Azithromycin After Loaded in Chitosan- and Tween 20-Based Oil-in-Water Macroemulsion for Acne Management. 2016 AAPS PharmSciTech pmid:26314246
Wei W et al. MPEG-PCL Copolymeric Micelles for Encapsulation of Azithromycin. 2018 AAPS PharmSciTech pmid:29675667
Wendel TD 1-day azithromycin was as effective as 7-day doxycycline for nongonococcal urethritis syndrome in men. 1996 Nov-Dec ACP J. Club pmid:8912627
Russo V et al. Azithromycin-induced QT prolongation in elderly patient. 2006 Acta Biomed pmid:16856707
Delmée M et al. In vitro susceptibilities of 180 clinical isolates of Haemophilus influenzae to ampicillin, amoxycillin/clavulanate, cefaclor, cefuroxime, cefotaxime, clarithromycin, and azithromycin. 1996 Acta Clin Belg pmid:8858889
Moi H et al. Spontaneous Regression of Untreatable Mycoplasma genitalium Urethritis. 2015 Acta Derm. Venereol. pmid:25634824
Cusini M Therapy for Gonococcal and Non-gonococcal Genital Infections is a Major Problem for Clinicians. 2015 Acta Derm. Venereol. pmid:25917593
Unemo M et al. Five-day Azithromycin Treatment Regimen for Mycoplasma genitalium Infection Also Effectively Eradicates Chlamydia trachomatis. 2015 Acta Derm. Venereol. pmid:25823977
Brkljacić N et al. Stevens-Johnson syndrome as an unusual adverse effect of azithromycin. 2006 Acta Dermatovenerol Croat pmid:16603101
Basta-Juzbasić A et al. A dose-finding study of azithromycin in the treatment of acne vulgaris. 2007 Acta Dermatovenerol Croat pmid:17868539
Innocenzi D et al. Moderate acne vulgaris: efficacy, tolerance and compliance of oral azithromycin thrice weekly for. 2008 Acta Dermatovenerol Croat pmid:18358103
Vcev A et al. Omeprazole, azithromycin and amoxicillin or amoxicillin plus clavulanic acid in eradication of Helicobacter pylori in duodenal ulcer disease. 1998 Acta Med Croatica pmid:9988898
Vladusić I et al. [Long term survival after Rhodococcus equi pneumonia in a patient with human immunodeficiency virus infection in the era of highly active antiretroviral therapy: case report and review]. 2006 Acta Med Croatica pmid:16933840
Dzelalija B et al. Randomized trial of azithromycin in the prophylaxis of Mediterranean spotted fever. 2002 Acta Med Croatica pmid:12596623
Hincapié JP et al. Microbiological effects of periodontal therapy plus azithromycin in patients with diabetes: results from a randomized clinical trial. 2014 Acta Odontol Latinoam pmid:25523961
Wirostko BM and Wirostko WJ The possible role of systemic azithromycin for idiopathic iridocyclitis. 2010 Acta Ophthalmol pmid:19891670
Lacroix JS et al. Symptoms and clinical and radiological signs predicting the presence of pathogenic bacteria in acute rhinosinusitis. 2002 Acta Otolaryngol. pmid:11936912
Edvinsson M et al. Chlamydophila pneumoniae in chronic rhinosinusitis. 2006 Acta Otolaryngol. pmid:16864493
Safak MA et al. A comparative study of azithromycin and pseudoephedrine hydrochloride for otitis media with effusion in children. 2001 Acta Otolaryngol. pmid:11813896
Otake H et al. Antimicrobial prophylaxis in tonsillectomy: the efficacy of preoperative single-dose oral administration of azithromycin in preventing surgical site infection. 2014 Acta Otolaryngol. pmid:24215215
García Callejo FJ et al. [Comparison of azithromycin, amoxicillin/clavulanic acid and cefaclor in the treatment of acute ENT infections]. 1998 Acta Otorrinolaringol Esp pmid:9707742
Bhattacharya MK et al. Azithromycin in the treatment of cholera in children. 2003 Acta Paediatr. pmid:12856976
Coulter JB et al. Nontuberculous mycobacterial adenitis: effectiveness of chemotherapy following incomplete excision. 2006 Acta Paediatr. pmid:16449024
Wasnik S et al. Preparation and characterization of floating drug delivery system of azithromycin. 2012 May-Jun Acta Pol Pharm pmid:22594266
Schémann JF et al. Longitudinal evaluation of three azithromycin distribution strategies for treatment of trachoma in a sub-Saharan African country, Mali. 2007 Acta Trop. pmid:17239332
Noedl H et al. Antimalarial activity of azithromycin, artemisinin and dihydroartemisinin in fresh isolates of Plasmodium falciparum in Thailand. 2001 Acta Trop. pmid:11495642
DeÄŸerli K et al. Efficacy of azithromycin in a murine toxoplasmosis model, employing a Toxoplasma gondii strain from Turkey. 2003 Acta Trop. pmid:12943976
Nakornchai S and Konthiang P Activity of azithromycin or erythromycin in combination with antimalarial drugs against multidrug-resistant Plasmodium falciparum in vitro. 2006 Acta Trop. pmid:17126280
Martín JM et al. Azithromycin for the Treatment of Ciclosporin-Induced Gingival Hyperplasia. 2016 Actas Dermosifiliogr pmid:26996332
Mathew A et al. Antimicrobial and Immunomodulatory Surface-Functionalized Electrospun Membranes for Bone Regeneration. 2017 Adv Healthc Mater pmid:28240815
Snapp B and Fischetti D Bordetella pertussis infection in infants: a reemerging disease. 2013 Adv Neonatal Care pmid:23532029
Woolard S and Kenkel D Heading off antibiotic resistance. 2001 Adv Nurse Pract pmid:12420432
Rodriguez WJ and Wiedermann BL The role of newer oral cephalosporins, fluoroquinolones, and macrolides in the treatment of pediatric infections. 1994 Adv Pediatr Infect Dis pmid:8123221
Dorfman MS et al. The pharmacodynamic properties of azithromycin in a kinetics-of-kill model and implications for bacterial conjunctivitis treatment. 2008 Adv Ther pmid:18369536
Luchs J Efficacy of topical azithromycin ophthalmic solution 1% in the treatment of posterior blepharitis. 2008 Adv Ther pmid:18781287
Gambhir M et al. Modelling trachoma for control programmes. 2010 Adv. Exp. Med. Biol. pmid:20632535
Siekmeier R et al. Inhalation of macrolides: a novel approach to treatment of pulmonary infections. 2015 Adv. Exp. Med. Biol. pmid:25252902
Mabey D Trachoma: recent developments. 2008 Adv. Exp. Med. Biol. pmid:18193660
Kyebambe P Incomplete Reiter's arthritis in a 23 year old nursing mother. 2004 Afr Health Sci pmid:15687073
Nasta P and Chiodera S Azithromycin for relapsing cerebral toxoplasmosis in AIDS. 1997 AIDS pmid:9233470
Hirbod T et al. HIV-neutralizing immunoglobulin A and HIV-specific proliferation are independently associated with reduced HIV acquisition in Kenyan sex workers. 2008 AIDS pmid:18356602
Steven N et al. Corticosteroid therapy for AIDS patients with Mycobacterium avium-intracellulare infection. 1994 AIDS pmid:8011231
Wawer MJ et al. A randomized, community trial of intensive sexually transmitted disease control for AIDS prevention, Rakai, Uganda. 1998 AIDS pmid:9677171
Bayoumi AM and Redelmeier DA Preventing Mycobacterium avium complex in patients who are using protease inhibitors: a cost-effectiveness analysis. 1998 AIDS pmid:9727572
Moyle GJ et al. Once weekly azithromycin as prophylaxis against recurrence of non-tuberculous mycobacterial infections in HIV-1-positive individuals. 1998 AIDS pmid:9727581
Jacobson JM et al. Dose-escalation, phase I/II study of azithromycin and pyrimethamine for the treatment of toxoplasmic encephalitis in AIDS. 2001 AIDS pmid:11316995